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Abstract
Backgrounds: Cervical cancer (CC) incidence remains unacceptably high in Côte d’Ivoire. In an effort to prevent
this malignant condition, a national CC screening program has been scaled up in the country. This study aimed at
assessing CC screening uptake and its associated factors in Abidjan in 2018.
Methods: A cross-sectional survey was conducted from July to September 2018 in the main healthcare facilities of
three randomly selected out of the eight health districts of Abidjan. During the study period, a standardized
questionnaire was administrated by research assistants to all women aged 25 to 55 years old, attending the three
participating facilities. Demographics, knowledge on CC, personal history of CC screening and reasons for not
attending CC screening were collected. A logistic regression model was computed to document factors associated
with reported CC screening uptake.
Results: A total of 1158 women with a median age of 32 years (IQR [27–36]), including 364 (31.4%) with no formal
education were included. Of those participants, 786 (67.9%) had ever heard about CC. CC screening uptake at least
once was reported by 7.5% [95% CI: 6.0–9.0] participants. In multivariable analysis, being ≥45 years (aOR: 6.2 [2.3–
17.2]), having a university level (aOR: 2.8 [1.2–6.6]) (versus non formal education) and access to mass campaign
information (aOR: 18.2 [8.5–39.1]) were associated with a reported CC screening uptake. The main reported barriers
to CC screening were unawareness towards CC screening (75.5%), negligence (20.5%), fear of CC detection (3.9%)
and fear of additional costs (3.3%).
Conclusion: CC screening uptake remains low despite current initiatives to support awareness and prevention in
Abidjan. Awareness campaigns need to be massively increased with the adjunction of tailored messages based on
the level of women’s education to enhance the CC screening coverage and reach the WHO goal of CC elimination
by 2030.
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Background
Cervical cancer (CC) is the fourth most common cancer
in women at a worldwide level with around 568,847 new
cases and 311,365 deaths according the International
Agency for Research on Cancer (IARC) [1]. Around 87%
of the CC-related deaths occurred in low and middle in-
come countries (LMICs) [2]. In 2018, approximately
1789 new cases and 1446 deaths were recorded in Côte
d'Ivoire making this malignancy the second most com-
mon cancer and the leading cause of mortality by cancer
in women [1].
The preponderant role of persistent oncogenic Human
Papillomavirus Virus (HPV) infection and the subsequent
long asymptomatic phase before invasive stages ensure
evidence that a significant proportion of the CC-related
burden could be prevented by HPV vaccine, early screen-
ing and precancerous lesions treatment [2]. In LMICs, as
Pap smear alternative, World Health Organization
(WHO) recommended the implementation of CC screen-
ing programs based on visual inspection (VI) or based on
oncogenic HPV detection where available [3]. In the be-
ginning of the last decade, some developing countries have
successfully implemented pilot VI-based screening pro-
grams in HIV clinics before scaling up them outside HIV
sites and towards their countries [4–6].
In Côte d'Ivoire, this program started in 2009 targeting
women living with HIV (WLHIV) aged under 55 years, be-
cause of the association between HIV and precancerous
lesions and CC [2]. This VI-screening program spread sig-
nificantly by extension in reproductive health services in
primary care and referral facilities in Abidjan and then in
almost all health districts of the country. For women who
were older, an invitation for a Pap smear test was pro-
posed outside project sites as well as to women at the 6–8
post-natal visit by gynaecologists [7, 8].
Despite the efforts of the Ministry of Health (MoH)
and civil society to increase access to CC screening, esti-
mates of CC screening coverage was low (1.2% in the
whole urban area of Abidjan) as demonstrated in a pre-
vious retrospective, population-based study in 2014 [7].
Since 2012, the program scaled up and all women aged
25 to 55 are invited to a screening each three years while
WLHIV were sensitized for an annual screening in HIV
clinics or HIV integrated facilities [9]. In 2019, according
to the National Cancer Control Program (NCCP), over
450 trained healthcare workers mainly midwives were
delivering CC screening through the “screen and treat”
approach by performing cryotherapy the same day when
applicable, irrespective of the women HIV status, in over
135 facilities, from primary and university health care
level, throughout Côte d’Ivoire [7, 9].
According to the recent WHO call towards CC elimin-
ation by 2030, countries should ensure that at least 70%
of their targeted population of women accessed to CC
screening by 35, and again by 45 years of age [10].
Therefore, there is a need for evaluating the efforts from
NCCP to prevent CC by updating data on CC screening
uptake in primary and secondary health care facilities in
Côte d'Ivoire. In addition, a better knowledge of factors
influencing CC screening uptake could help in the defin-
ition of health priorities and lead to appropriate actions
to improve CC screening programs in LMICs.
This study aimed at assessing CC screening uptake
and its associated factors among women living in Abi-
djan, the economic capital of Côte d’Ivoire.
Methods
Study design
A cross-sectional study was performed from July to Sep-
tember 2018 in three health facilities of Abidjan, the
economic capital of Côte d'Ivoire. Abidjan is a cosmo-
politan and the most populous town of Côte d'Ivoire,
with 4,707,404 inhabitants, representing a quarter of the
overall population of the country [11].
Setting and participants
Among the eight health districts of Abidjan, three were
randomly selected. In each of these three districts, one
healthcare facility from primary or secondary level was
selected based on a short list of facilities where the
sanitary area was high and the frequentation of popula-
tion was optimal. Three facilities (“general hospital of
Bingerville”, “general hospital of Adjamé” and “Urban
community-based health facility of Yopougon-Andokoi”)
were then conveniently selected. Of note, General hospi-
tals are secondary level health facilities with health
workers trained to perform various health services in-
cluding surgical pathologies management while the
urban community-based facilities deliver mainly primary
care services.
During the study period, all women aged 25 to 55
years old, attending the selected healthcare facility were
approached to participate in the survey, regardless of the
reason for attendance. Each day, a list of eligible women
was created at the desk entrance and allowed to record
all women eligible to the survey.
Data collection
A standardized questionnaire was adapted from a previ-
ous form, administered to WLHIV for the same purpose
[12]. This standardized questionnaire was administrated
to each participant in a dedicated office by trained
healthcare workers (medical doctors and midwives) to
collect sociodemographic characteristics including age,
educational level, marital status, monthly income and
possession of communication-related equipment, know-
ledge of CC and its risk factors, symptoms and preven-
tion tools. In addition, the history of CC screening was
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also assessed as well as the barriers of CC screening by
collecting reasons for no. Participants who previously
heard about CC were asked some questions including
the origin and clarity of information on CC, knowledge
of CC symptoms, prevention methods and risk factors.
A CC screening uptake was defined by having ever
screened at least once in a lifetime regardless of the
screening method (cytology, visual inspection or others).
Data collection and statistical analysis
Data were captured in a dedicated database created
under Epidata 3.1 and exported to STATA 14.0 (Stata-
Corp, College Station, Texas) for statistical analysis. Nu-
merical variables were described as medians and
interquartile range (IQR) while categorical variables were
described as frequencies with percentages and compared
using Chi square test and Fisher exact when appropriate.
Results with a p value < 0.05 were considered statistically
significant. A logistic regression model was used to de-
termine factors associated with CC screening uptake
among women in general population in Abidjan through
a step-wise backward procedure. As first step, variables
associated with CC screening uptake with a p-value
≤0.20 were included in the full model. Then, variables
that were not statistically associated with CC screening
uptake and did not add any significant prediction to the
model were subsequently removed. A < 0.05 was retained
for statistical significance in final multivariable model..
Association between CC screening uptake and explana-
tory variables were estimated using adjusted odds ratios
(aOR) with their associated 95% confidence intervals
(IC).
Ethical consideration
The present research has been performed in accordance
with the Declaration of Helsinki and all methods were
performed in accordance with the relevant guidelines
and regulations. The study did not require approval
from the national ethics committee of Côte d’Ivoire for
the following reasons: first, the research did not include
any planned intervention by the researcher; second, the
women targeted by the research did not experience an
invasion of privacy; third, no dissemination of the re-
search findings would identify specific individuals. Based
on the national ethics committee notice, the Ministry of
Health provided administrative clearance to use and
analyze data collected through its NCCP. This study was
a part of a wide evaluation program of the CC screening
initiatives in Côte d'Ivoire, which was authorized by a
letter from the NCCP. Written informed consent was
obtained from each of participant before the administra-
tion of the questionnaire. Participants confidentiality and
privacy were ensured through anonymous questionnaire




Overall, during the study period, 1172 eligible women
attending the participating facilities were asked to par-
ticipate in the study. For lack of time, 14 (1.2%) declined.
Finally, 1158 women were enrolled with a median age of
32 years (IQR: [29–42]). Among them, 648 (56%) had
primary or no education level, 764 (66%) were married
or living with a sexual partner. In regards to monthly in-
come, 651 (56.2%) of participants had less than the mini-
mum wage in Côte d'Ivoire (60,000 XOF = ~ 120 USD).
In addition, 1099 (94.9%) participants owned a television
and 1110 (95.9%) at least one mobile phone. Radio and
internet access through smartphone were owned by 896
(77.4%) and 379 (32.7%) participants, respectively.
Table 1.
Knowledge on cervical cancer screening
Among the participants, 786 (67.9%) had ever heard
about CC, higher in women with university level (96.1%,
n = 224) compared to primary/secondary (68.6%, n =
385) or no formal (48.6%, n = 177) education (p < 0.001).
Their main source of information towards CC was me-
dias (61.2%, n = 481), relatives (20.7%, n = 163), hospital
through healthcare workers (14.5%, n = 114) and mass
campaigns (7.3%, n = 57). Among the 786 who ever
heard about CC, information on CC was not considered
as clear for 672 (85.5%) participants. Table 2.
In addition, CC was known as a preventable disease
for 469 (59.7%) participants, higher in University (73.2%,
n = 164) compared to primary/secondary (57.4%, n =
221) or no formal education (47.5%, n = 84) groups (p <
0.001). Regarding CC risk factors, HIV infection, mul-
tiple sexual partners and early sexual initiation were
known as contributing to CC for 91 (11.6%), 194 (24.7%)
and 185 (23.5%) participants, respectively.
Cervical cancer screening uptake
Overall, the proportion of CC screening uptake was
7.5% [95% CI: 6.0–9.0]. Among the 87 who had ever
been screened for CC, 45 (51.7%) and 42 (48.3%) were
screened through VI and pap smear, respectively. A re-
ported CC screening was completed following mass
awareness campaigns and after recommendation from a
healthcare worker through 6–8 post-delivery visit for 38
(43.6%) and 36 (41.4%) women, respectively. A self-
initiative was reported by 13 (14.9%) women.
Reasons for no CC screening uptake
Among the 699 participants with no history of CC
screening, reasons of not attending screening were lack
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of sufficient knowledge on CC (75.5%, n = 528), careless-
ness or negligence (20.5%, n = 143), fear of cancer (3.9%,
n = 27), fear of additional costs (3.3%, n = 23) and the
fear of a bad reception at CC screening facility (0.3%,
n = 2). Carelessness (230.3%) was common among
women with university level (p < 0.001) while the lack of
sufficient knowledge on CC (85.6%) were the highest re-
ported reason in no formal education one else (p <
0.001).
Associated factors with cervical cancer screening uptake
In multivariate analysis, being ≥45 years (aOR: 6.2 [2.3–
17.2]), having a university level versus no formal educa-
tion (aOR: 2.8 [1.2–6.6]), receiving an information on
CC considered as clear (aOR: 2.6 [1.9–3.4]) and access
to mass campaign information (aOR: 18.2 [8.5–39.1])
were associated with CC screening uptake. Table 3.
Discussion
In this study, we report a low CC screening uptake
among women attending primary and secondary health-
care facilities in the urban area of Abidjan, Côte d'Ivoire.
Access to a comprehensive information about CC and
being reached through mass awareness campaign were
identified as major determinants in uptake to CC screen-
ing. In addition, the most important barrier to CC
screening uptake reported by women was the lack of suf-
ficient knowledge about CC, far behind economic
considerations.
Estimated uptake of CC screening is lower than previ-
ous studies conducted in Nigeria, Ethiopia, Kenya and
Cameroon which reported rates ranging from 19.6 to
43.5% [13–16]. A similar finding of 7.8% was reported
from Tanzania while the lowest rate was reported from
Zimbabwe (3.8%) [17, 18]. The low access to screening
services among women in our population could be partly
explained by their relatively young age. Indeed, the
young profile of our population study could explain
partly this low rate compared to participants from
Cameroon and Ethiopia where the median age was 41
and 36 years, respectively. Furthermore, the significant
association between older age especially in peri-
menopausal women and CC screening uptake found in
this study rightfully point out the interest for screening
gained as the age progresses. Though this survey re-
ported a low awareness regarding CC and its prevention
method, the higher estimate of CC screening uptake
found in this study compared with the CC screening
coverage of 1.2% reported previously in a five-years
population-based survey (2010–2014). This potential in-
crease in CC screening uptake should encourage NCCP
leaders to pursue their efforts [7].









n (%) n (%) n (%)
Age, years median (IQR*) 32 [27–36] 37 [30–43] 32 [26–38] –
≤ 35 854 (73.7) 39 (44.8) 815 (76.1) < 0.001
> 35 304 (26.3) 48 (55.2) 256 (23.9)
Marital status
Single 394 (34.0) 26 (29.9) 368 (34.4) 0.40
Living with a partner 764 (66.0) 61 (70.1) 703 (65.6)
Monthly income (USDα)
≤ 40 or none 110 (9.5) 8 (9.2) 102 (9.5) < 0.001
40–160 639 (55.2) 25 (28.7) 614 (57.3)
≥ 160 409 (35.3) 54 (62.1) 355 (33.2)
Educational level
No formal 364 (31.4) 9 (10.3) 355 (33.1) < 0.001
Primary or Secondary 561 (48.5) 42 (48.3) 519 (48.5)
University 233 (20.1) 36 (41.4) 197 (18.4)
Possession of communication equipment
Television 1099 (94.9) 86 (98.9) 1013 (94.6) 0.22
Radio 896 (77.4) 72 (82.8) 824 (76.9) 0.71
At least one mobile phone 1110 (95.9) 84 (96.6) 1026 (95.8) 0.89
Internet connexion through smartphone 379 (32.7) 51 (58.6) 328 (30.6) < 0.001
*IQR: Inter Quartile Range; αUSD: United States Dollars
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In all cases, this study demonstrated a limited ac-
cess to CC screening services in Abidjan by women
from general population compared to their HIV-
infected counterparts. In 2017, a previous cross-
sectional survey in Abidjan revealed that
96.1%WLHIV on antiretroviral treatment had heard
about CC yielding a greater CC screening uptake
with nearly two-third (59.7%) ever being screened
[12]. This significantly higher CC screening uptake
was likely related to early sensitization and screening
pilot project in HIV clinics. Despite the scale up of
CC screening, there seems to be an unmet need in
the coverage of the target population for whom
those current mass communication campaigns were
designed for as defined by national authorities.
Though older women and WLHIV are both highly
vulnerable population to CC, younger women also
need to be reached with those messages, especially
for prevention purposes. CC being among the most
preventable forms of cancer, integrating CC screen-
ing habits into a lifestyle at a young age would guar-
antee early detection of potential cancerous lesions.
Additional efforts in targeting younger women
should be done by NCCP and program partners in
the perspective of prevention of CC.
Table 2 Knowledge and attitudes towards cervical cancer stratified by education level among women who have ever heard about











N (%) n (%) n (%) n (%)
Place where ever heard about CC*
In an hospital 114 (14.5) 15 (8.5) 58 (15.1) 41 (18.3) 0.021
Heard about CC* in the media 481 (61.2) 103 (58.2) 236 (61.3) 142 (63.4) 0.378
Heard about CC* during campaigns 57 (7.3) 10 (5.7) 28 (7.3) 19 (8.5) 0.575
Heard about CC* through relativesμ 163 (20.7) 53 (29.9) 73 (19.0) 37 (16.5) 0.007
Clarity of received CC* information
Not clear / I did not understand 672 (85.5) 163 (92.1) 338 (87.8) 171 (76.3) < 0.001
Very Clear / I understand it 114 (14.5) 14 (7.9) 47 (12.2) 53 (23.7)
Symptoms of CC* are
Genital bleeding 184 (23.4) 27 (15.3) 87 (22.6) 70 (31.3) 0.004
Leucorrhoea 110 (14.0) 21 (11.9) 45 (11.7) 44 (19.6) < 0.001
Abdominal Pain 123 (15.7) 16 (9.0) 46 (12.0) 61 (27.2) < 0.001
CC* is a preventable
Yes 469 (59.7) 84 (47.5) 221 (57.4) 164 (73.2) < 0.001
No 161 (20.5) 43 (24.3) 88 (22.9) 30 (13.4)
Means of prevention for CC* (N = 469)
Screening 385 (82.1) 55 (65.5) 182 (82.4) 148 (90.2) < 0.001
Vaccine 151 (32.2) 21 (25.0) 77 (34.8) 53 (32.3) < 0.001
Risk factors for CC*
HIV infection 91 (11.6) 7 (4.0) 31 (8.1) 53 (23.7) < 0.001
Multiple sexual partners 194 (24.7) 27 (15.3) 78 (20.3) 89 (39.7) < 0.001
Early sexual initiation 185 (23.5) 22 (12.4) 74 (19.2) 89 (39.7) < 0.001
Reasons for no CC screening uptake (N = 699)
Unawareness towards CC screening 528 (75.5) 143 (85.6) 266 (77.3) 119 (63.3) < 0.001
Negligence 143 (20.5) 15 (9.0) 71 (20.6) 57 (30.3) < 0.001
Fear of being diagnosed cancer 27 (3.9) 4 (2.4) 18 (5.2) 5 (2.7) 0.212
Fear of additional costs 23 (3.3) 5 (3.0) 6 (1.7) 12 (6.4) 0.016
Fear of a bad reception 2 (0.3) – – 1 (0.3) 1 (0.5) 0.53
*CC: cervical cancer; μrelatives: parents, friends or living partner; ∞Respondents had the possibility to choose over one choice; £only respondents for each variable
among participants who ever heard about CC were considered, missing category was not specified; Except for the “total column”, proportions represent the number of
women for each modality out of all women in the education level category
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That involves an aggressive communication in com-
munities and a systematic proposition for screening to
all women seeking a hospital, regardless the purpose of
the visit.
This study revealed that the comprehension of the
messages on CC is a determinant of the decision to
undergo screening. Women who estimated being well
informed had positive attitudes towards screening com-
pared to those who were ill-informed. There is an urgent
need for improving clear information about CC among
communities by tailoring messages according to cultural
habits and age-groups behaviors. A recent meta-analysis
underlined the positive impact of culturally tailored edu-
cation interventions on raising attendance for screening
[19]. These messages should include necessarily key
points such as (i) the serious concern that represents CC
and its preventable aspect (can be cured if diagnosed
early), (ii) the possibility to prevent it through regular
screenings and complete immunization by HPV vaccine
and (iii) the safety and effectiveness of prevention
methods for CC mortality reduction [20]. In this per-
spective, the MoH must ensure that healthcare workers
and peer-communities have adequate skills and know-
ledge on CC and their ability to communicate these key
messages. The success of the cervical cancer screening
program is based upon solid training of all stakeholders
involved in mass awareness campaigns across the
country.
Despite growing efforts to scale-up systematic CC
screening in Côte d'Ivoire, it still remains mainly
Table 3 Factors associated with CC screening uptake among women previously aware of CC in Abidjan, Côte d’Ivoire, 2018 (N =
786)
Variables CCS¥ uptake Multivariable analysis (initial model) Multivariable analysis (final model)
n/N* % OR (CI 95%) p value aOR (CI 95%) p
value
Age (years)
≤ 30 21/383 5.5 1 – 1 –
[30–45[ 56/359 15.6 2.5 (1.4–4.7) 0.003 3.0 (1.6–5.5) < 0.001
≥ 45 10/44 22.7 5.1 (1.8–14.3) 0.002 6.2 (2.3–17.2) < 0.001
Marital status
Single 27/291 9.3 1 – – –
Living with a partner 60/495 12.1 1.4 (0.8–2.6) 0.216 – –
Educational level
No formal 10/177 5.7 1 – – –
Primary or Secondary 41/385 10.7 1.9 (0.8–4.3) 0.142 1.9 (0.9–4.2) 0.126
University 36/224 16.1 2.5 (1.0–6.0) 0.045 2.8 (1.2–6.6) 0.017
Monthly income (αUSD)
≤ 40 USD 8/69 11.6 1
40–160 25/397 6.3 1.0 (0.4–2.6) 0.964 – –
≥ 160 54/320 16.9 0.7 (0.4–1.3) 0.213 – –
Source of information on CC¥
Through medias 25/529 4.7 1 – –
In an hospital 22/87 25.3 6.1 (2.9–12.5) < 0.001 5.8 (2.8–11.8) < 0.001
Through relatives£ 17/115 14.8 2.6 (1.2–5.3) 0.012 2.7 (1.3–5.6) 0.008
During a mass campaign 23/55 41.8 17.6 (8.1–37.9) < 0.001 18.2 (8.5–39.1) < 0.001
Clarity of information
Not clear for me 42/672 6.3 1 – 1 –
Very clear for me 45/114 39.5 2.3 (1.7–3.1) < 0.001 2.6 (1.9–3.4) < 0.001
Knowing CC¥ as a preventable disease
vNo 15/317 4.7 1 – –
Yes 72/469 15.4 1.8 (0.9–3.6) 0.072 – –
¥CCS: Cervical Cancer Screening
*n/N: number of women who had ever been screened for CC/Number of women per category
£Relatives: friends or parents; αUSD: United States Dollars
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opportunistic at the population level and there is no
organised program inviting women to regular screening
with incentives and reminder support. Meanwhile, mass
campaign information related to CC screening are multi-
plying and relayed by various media supports. This
translates into a growing number of women being aware
of CC screening but still a limited effective access to CC
screening. The present study was not designed to for-
mally assess the precise impact of mass CC screening
programs. However, in our study, being informed on CC
screening through mass campaign was strongly associ-
ated with CC screening uptake supporting the usefulness
of this communication process. Generally, during mass
awareness campaigns, sensitization and often screening
are offered free of charge, unlike in healthcare facilities
routinely delivering CC screening where at least 5 USD
are required for a VI test. These activities, mainly con-
ducted by NGOs are preceded by mass and social media
promotion yielding an increase in women participation.
They are more and more regular in the context of
Côte d'Ivoire, with recently a frank involvement of reli-
gious and administrative leaders. Despite the scale up of
CC prevention, these findings inform future efforts in
terms of strengthening CC screening services utilization
by increasing mass awareness campaign in both peri-
urban and rural settings. In fact, poor conditions in
which populations are living impact the success of pre-
vention strategies, as illustrated in Burkina Faso [21] and
Nigeria [22]. Therefore, strategies aiming at bringing CC
screening closer to women by mitigating geographic and
financial barriers in LMICs should be encouraged. Glo-
bal mobilization, added with the pursuit of a structured
and continuous program of creation of proximity sites,
should be the key to achieve the ambitious 70% cover-
age, set by the MoH. Civil society initiatives, community
mobilization through more and effectiveness engage-
ment of their leaders should resulted in increasing of CC
screening awareness and CC screening uptake. In fact,
women in general population should be more exposed
to CC screening, through both hospital-based and
community-based strategies. That requires a better
organization and an empowerment of all NGOs engaged
in CC control and a close collaboration with the NCCP
for a better optimization of CC information penetration
and to guarantee an equitable access to screening ser-
vices across all the districts of the country. Besides, this
whole organization must be evaluated by reinforcing
monitoring activities, initiated at national level through
the District Health Information Software (DHIS2) only
recently, and therefore be more useful for policy makers.
In fact, because of funding constraints, regular monitor-
ing activities through aggregated data and key perform-
ance indicators are lacking in Côte d'Ivoire. As sustained
CC screening initiatives expand in the country, the
NCCP should list these monitoring activities as a key
priority, while addressing the need to standardize indica-
tors on CC prevention along with care continuum, from
all primary and secondary healthcare facilities, regardless
their HIV management status-clinics or integrated.
Limitations
Our study has some limitations despite the useful infor-
mation provided. First, the use of CC screening services
was self-reported exposing to desirability bias. No verifi-
cation has been done despite the required details on the
visit for CC screening (date, professional status of pro-
vider and facility). However, this study used a structured
questionnaire previously validated and tested in WLHIV
for assessment of CC screening uptake [12]. Second, this
study was conducted among women attending a limited
number of healthcare facilities from public sector, in the
capital of the country because of organisational aspects
and financial procedures which did not allow the execu-
tion of the initial plan. The findings from this study may
not be representative of women attending the private
sector and form the whole country including rural set-
tings where CC uptake could be the lowest because of
socioeconomic inequities and geographical barriers to
CC screening. Nevertheless, a multistage sampling pro-
cedure and a rigorous participant selection in facilities
from two different levels of the health system were ap-
plied to limit potential selection bias.
Conclusion
The CC screening uptake remains low in the context of
constraining-resources and low literacy rate settings
such as Abidjan, despite the commitment of the health
authorities. Mass awareness campaigns need to be in-
creased with the adjunction of tailored messages based
on the level of women’s education to enhance the CC
screening coverage. As efforts are undertaken by the
NCCP to promote a wider and sustainable access to CC
screening in the country, monitoring activities are also
one of the key priorities that need to be reinforced to
evaluate the impact of this preventive strategy at a popu-
lation level through standardized aggregated indicators.
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